middle.news
Zelira waits on US$33M funding as HOPE 1 FDA program remains on hold
12:26pm on Friday 30th of October, 2026 AEDT
•
Biotechnology and Pharmaceuticals
Read Story
Zelira waits on US$33M funding as HOPE 1 FDA program remains on hold
12:26pm on Friday 30th of October, 2026 AEDT
Key Points
US$32.98 million HOPE 1 SPV fundraising remains delayed
A$47,000 cash balance and 0.8 quarters of estimated funding
FDA IND submission and Phase 1 dosing depend on funding close
Overdue financial statements still need to be lodged
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Zelira Therapeutics (ASX:ZLD)
OPEN ARTICLE